| Name: | OMRIX BIOPHARMACEUTICALS, INC. |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 06 Apr 2006 (19 years ago) |
| Entity Number: | 3345221 |
| ZIP code: | 10005 |
| County: | New York |
| Place of Formation: | Delaware |
| Address: | 28 LIBERTY STREET, NEW YORK, NY, United States, 10005 |
| Principal Address: | ROUTE 22 WEST, SOMERVILLE, NJ, United States, 08876 |
| Plan Name | Plan Year | EIN/PN | Received | Sponsor | Total number of participants | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OMRIX BIOPHARMACEUTICALS INC 401(K) PROFIT SHARING PLAN & TRUST | 2015 | 522147005 | 2016-07-20 | OMRIX BIOPHARMACEUTICALS INC | 7 | |||||||||||||||||||||
|
||||||||||||||||||||||||||
| Role | Plan administrator |
| Date | 2016-07-19 |
| Name of individual signing | JANINE CONNELL |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | Agent | 28 LIBERTY ST., NEW YORK, NY, 10005 |
| Name | Role | Address |
|---|---|---|
| OMRIX BIOPHARMACEUTICALS, INC. | DOS Process Agent | 28 LIBERTY STREET, NEW YORK, NY, United States, 10005 |
| Name | Role | Address |
|---|---|---|
| NISHA JOHNSON | Chief Executive Officer | ROUTE 22 WEST, SOMERVILLE, NJ, United States, 08876 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2024-04-15 | 2024-04-15 | Address | ROUTE 22 WEST, SOMERVILLE, NJ, 08876, USA (Type of address: Chief Executive Officer) |
| 2020-04-22 | 2024-04-15 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
| 2019-01-28 | 2024-04-15 | Address | 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Registered Agent) |
| 2018-04-05 | 2024-04-15 | Address | ROUTE 22 WEST, SOMERVILLE, NJ, 08876, USA (Type of address: Chief Executive Officer) |
| 2018-04-05 | 2020-04-22 | Address | 111 EIGHTH AVENUE, NEW YORK, NY, 10011, USA (Type of address: Service of Process) |
| 2016-04-04 | 2018-04-05 | Address | ROUTE 22 WEST, SOMERVILLE, NJ, 08876, USA (Type of address: Chief Executive Officer) |
| 2011-11-03 | 2016-04-04 | Address | ROUTE 22 WEST, SOMERVILLE, NJ, 08876, USA (Type of address: Chief Executive Officer) |
| 2009-07-06 | 2019-01-28 | Address | 111 EIGHTH AVENUE, NEW YORK, NY, 10011, USA (Type of address: Registered Agent) |
| 2009-07-06 | 2018-04-05 | Address | 111 EIGHTH AVENUE, NEW YORK, NY, 10011, USA (Type of address: Service of Process) |
| 2008-11-20 | 2009-07-06 | Address | 1120 AVE OF THE AMERICAS, 4TH FL, NEW YORK, NY, 10036, USA (Type of address: Service of Process) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 240415003097 | 2024-04-15 | BIENNIAL STATEMENT | 2024-04-15 |
| 220425002222 | 2022-04-25 | BIENNIAL STATEMENT | 2022-04-01 |
| 200422060371 | 2020-04-22 | BIENNIAL STATEMENT | 2020-04-01 |
| SR-43637 | 2019-01-28 | CERTIFICATE OF CHANGE (BY AGENT) | 2019-01-28 |
| 180405006022 | 2018-04-05 | BIENNIAL STATEMENT | 2018-04-01 |
| 160404007731 | 2016-04-04 | BIENNIAL STATEMENT | 2016-04-01 |
| 140402006295 | 2014-04-02 | BIENNIAL STATEMENT | 2014-04-01 |
| 120412006003 | 2012-04-12 | BIENNIAL STATEMENT | 2012-04-01 |
| 111103002181 | 2011-11-03 | BIENNIAL STATEMENT | 2010-04-01 |
| 090706000157 | 2009-07-06 | CERTIFICATE OF CHANGE | 2009-07-06 |
| Docket Number | Nature of Suit | Filing Date | Disposition | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0809196 | Civil Rights Employment | 2008-10-27 | other | |||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Name | TANG |
| Role | Plaintiff |
| Name | OMRIX BIOPHARMACEUTICALS, INC. |
| Role | Defendant |
| Circuit | Second Circuit |
| Origin | original proceeding |
| Jurisdiction | diversity of citizenship |
| Jury Demand | Neither plaintiff nor defendant demands jury |
| Demanded Amount | 650000 |
| Termination Class Action | Missing |
| Procedural Progress | order entered |
| Nature Of Judgment | no monetary award |
| Judgement | plaintiff |
| Arbitration On Termination | Missing |
| Office | 1 |
| Filing Date | 2020-01-15 |
| Termination Date | 2020-09-15 |
| Section | 1332 |
| Sub Section | BC |
| Status | Terminated |
Parties
| Name | OMRIX BIOPHARMACEUTICALS, INC. |
| Role | Plaintiff |
| Name | WALLER CAPITAL PARTNERS, LLC |
| Role | Defendant |
Date of last update: 28 Mar 2025
Sources: New York Secretary of State
